SARANAC LAKE - Trudeau Institute is a subcontractor on a $3 million research grant that will help move one of its discoveries closer to human trials and clinical use, the nonprofit biomedical research center announced today.
Trudeau faculty scientist Stephen Smiley is a co-investigator on a $3 million National Institute of Allergy and Infectious Diseases Small Business Innovation Research grant awarded to Aronora Inc. The Oregon-based company is developing a new class of safe therapeutics for thrombotic disorders, including infections that cause blood-clotting abnormalities.
Smiley's lab will determine which types of bacterial infections respond to Aronora's therapeutic approach, which has helped mice survive severe infections caused by listeria, a bacteria that can cause serious illness among the elderly, the very young and those with compromised immune systems.
Article Photos
Stephen Smiley
(Photo courtesy of Trudeau Institute)
"The goal is now to determine whether this same approach will also work for other types of bacterial infections," Smiley said in a press release.
The is the institute's first SBIR grant.